Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12110491 Selective reduction of allelic variants

Patent 12110491 was granted and assigned to Ionis Pharmaceuticals on October, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Ionis Pharmaceuticals
Ionis Pharmaceuticals
0
Date Filed
January 18, 2022
0
Date of Patent
October 8, 2024
0
Patent Applicant
Ionis Pharmaceuticals
Ionis Pharmaceuticals
0
Patent Application Number
17577832
0
Patent Citations
‌
US Patent 8957040 Selective reduction of allelic variants
0
‌
US Patent 9006198 Selective reduction of allelic variants
0
‌
US Patent 9688985 MicroRNA compounds and methods for modulating miR-21 activity
0
‌
US Patent 9695418 Oligomeric compounds comprising bicyclic nucleosides and uses thereof
0
‌
US Patent 9752142 Gapped oligomeric compounds comprising 5′-modified deoxyribonucleosides in the gap and uses thereof
0
‌
US Patent 9914922 Oligomeric compounds comprising bicyclic nucleotides and uses thereof
0
‌
US Patent 10017764 Oligomeric compounds comprising bicyclic nucleotides and uses thereof
0
‌
US Patent 10202599 Selective antisense compounds and uses thereof
0
‌
US Patent 10260069 Selective antisense compounds and uses thereof
0
‌
US Patent 10337007 Oligomeric compounds comprising bicyclic nucleotides and uses thereof
0
•••
Patent Inventor Names
Susan M. Freier
0
Eric E. Swayze
0
C. Frank Bennett
0
Sarah Greenlee
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12110491
0
Patent Primary Examiner
‌
Ekaterina Poliakova-Georgantas
0

Find more entities like US Patent 12110491 Selective reduction of allelic variants

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.